High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin

References

• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469–80
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351–75
   PubMed Web of Science ®Google Scholar
• Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: result from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 2005;112:658–65
   PubMed Web of Science ®Google Scholar
• Sun S, Wu H, Zhang Q, et al. Subnormal peripheral blood leukocyte counts are related to the lowest prevalence and incidence of metabolic syndrome: Tianjin chronic low-grade systemic inflammation and health cohort study. Mediators Inflamm 2014;Article ID 412386
   Google Scholar
• Zhang WH, Xue P, Yao MY, et al. Prevalence of metabolic syndrome and its relationship with physical activity in suburban Beijing, China. Ann Nutr Metab 2013;63:298–304
   PubMed Web of Science ®Google Scholar
• Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747–57
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415–28
   PubMed Web of Science ®Google Scholar
• Eberly LE, Prineas R, Cohen JD, et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006;29:123–30
   PubMed Web of Science ®Google Scholar
• Marroquin OC, Kip KE, Kelley DE, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the women’s Ischemia syndrome evaluation. Circulation 2004;109:714–21
   PubMed Web of Science ®Google Scholar
• Tseng LN, Tseng YH, Jiang YD, et al. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000–2009. J Formos Med Assoc 2012;111:625–36
   PubMed Web of Science ®Google Scholar
• Franco OH, Massaro JM, Civil J, et al. Trajectories of entering the metabolic syndrome: the Framingham heart study. Circulation 2009;120:1943–50
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–72
   PubMed Web of Science ®Google Scholar
• Natali A, Muscelli E, Casolaro A, et al. Metabolic characteristics of prehypertension: role of classification criteria and gender. J Hypertens 2009;27:2394–402
   PubMed Web of Science ®Google Scholar
• About Tianjin. 2013. Available from: http://www.tj.gov.cn/english/About_tianjin/Tianjin_Basic_Facts/Population_and_Nationalities/
   Google Scholar
• Vartiainen E, Du DJ, Marks JS, et al. Mortality, cardiovascular risk factors, and diet in China, Finland, and the United States. Public Health Rep 1991;106:41–6
   PubMed Web of Science ®Google Scholar
• Er LK, Chen YL, Pei D, et al. Increased incidence of metabolic syndrome in older men with high normotension. Aging Male 2012;15:227–32
   PubMed Web of Science ®Google Scholar
• Hageman PA, Pullen CH, Hertzog M, et al. Associations of cardiorespiratory fitness and fatness with metabolic syndrome in rural women with prehypertension. J Obes 2012;2012:618728
   PubMedGoogle Scholar
• Hsu CH, Lin JD, Wu CZ, et al. High mormotension is associated with higher metabolic syndrome risk in postmenopausal women. Geriatr Gerontol Int 2014;14:293–300
   PubMed Web of Science ®Google Scholar
• Grotto I, Grossman E, Huerta M, et al. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006;48:254–9
   PubMed Web of Science ®Google Scholar
• Yu D, Huang J, Hu D, et al. Prevalence and risk factors of prehypertension among Chinese adults. J Cardiovasc Pharmacol 2008;52:363–8
   PubMed Web of Science ®Google Scholar
• Ferguson TS, Younger NO, Tulloch-Reid MK, et al. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord 2008;8:20
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Kohara K, Tabara Y, et al. Insulin resistance and prevalence of prehypertension and hypertension among community-dwelling persons. J Atheroscler Thromb 2010;17:148–55
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Lewis CE, McTifue KM, Burke LE, et al. Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation 2009;119:3263–71
   PubMed Web of Science ®Google Scholar
• Okosun IS, Boltri JM, Anochie LK, et al. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risks of abdominal obesity. J Hum Hypertens 2004;18:849–55
   PubMed Web of Science ®Google Scholar
• Tsai PS, Ke TL, Huang CJ, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005;23:1355–60
   PubMed Web of Science ®Google Scholar
• Hwu CM, Liou TL, Hsiao LC, et al. Prehypertension is associated with insulin resistance. QJM 2009;102:705–11
   PubMed Web of Science ®Google Scholar
• Oda E, Kawai R. High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women. Br J Biomed Sci 2011;68:29–33
   PubMed Web of Science ®Google Scholar
• Cordero A, Laclaustra M, Leon M, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens 2006;19:189–96 (discussion 197–8)
   PubMed Web of Science ®Google Scholar
• Oda E, Kawai R. LDL cholesterol is associated with blood pressure in Japanese women. Diabetes Care 2009;32:e113
   PubMedGoogle Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–357
   PubMed Web of Science ®Google Scholar